📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
0 analysed today
FollowTelegram
0
Today
152,139
All-time analysed
43,645
Positive
6,747
Negative
92,898
Neutral
8,781
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
23 announcements match the current filters (relevance ≥ 5).
Panacea Biotec appoints Ankit Jain as Company Secretary w.e.f. Dec 16, 2025
Panacea Biotec Limited announced the appointment of Mr. Ankit Jain as the Company Secretary & Compliance Officer, effective December 16, 2025. This follows the cessation of Mr. Vinod Goel from the role of Company Secretary and Compliance Officer on December 15, 2025, due to his appointment as Group CFO. Mr. Jain, aged about 38 years, previously served as Assistant General Manager - Legal of the company’s wholly owned subsidiary, Panacea Biotec Pharma Ltd. The board also revised the policy for determining materiality of events and authorized key managerial personnel for disclosures.
Key Highlights
Ankit Jain appointed as Company Secretary & Compliance Officer w.e.f. December 16, 2025
Vinod Goel appointed as Group CFO and Head Legal & Corporate Governance w.e.f. December 16, 2025
Vinod Goel ceases to be Company Secretary and Compliance Officer w.e.f. December 15, 2025
Ankit Jain has around 15 years of experience in corporate governance
Board meeting concluded at 03:36 P.M. on December 15, 2025
👀 What to Watch
Investors should monitor the company's filings and announcements for further updates on key managerial personnel changes and strategic direction. No immediate action is required.
Panacea Biotec Appoints Vinod Goel as Group CFO and Ankit Jain as Company Secretary
Panacea Biotec Limited has announced a restructuring of its Key Managerial Personnel (KMP) effective December 16, 2025. Following the resignation of CFO Devender Gupta, the company has elevated Mr. Vinod Goel, a veteran with the firm since 1999, to the position of Group Chief Financial Officer. Simultaneously, Mr. Ankit Jain, who has 15 years of experience and was previously with the company's subsidiary, has been appointed as the new Company Secretary and Compliance Officer. These internal transitions aim to ensure leadership continuity and stable corporate governance.
Key Highlights
Mr. Vinod Goel appointed as Group CFO and Head Legal & Corporate Governance effective December 16, 2025.
Mr. Ankit Jain appointed as Company Secretary and Compliance Officer effective December 16, 2025.
Outgoing CFO Mr. Devender Gupta's resignation is effective from December 15, 2025.
Mr. Vinod Goel brings over 35 years of experience and has been with Panacea Biotec for approximately 26 years.
The Board updated its policy for determining materiality and authorized 7 KMPs for regulatory disclosures.
👀 What to Watch
No immediate action is required as the appointments represent an internal succession plan, which typically suggests stability in financial and legal operations.
Panacea Biotec appoints Vinod Goel as CFO, effective Dec 16, 2025
Panacea Biotec has appointed Mr. Vinod Goel as the Chief Financial Officer (CFO) with effect from December 16, 2025. Mr. Goel, who is currently the Group CFO and Head Legal & Company Secretary, will now be designated as Group Chief Financial Officer and Head Legal & Corporate Governance. This follows the resignation of Mr. Devender Gupta from the CFO position, effective December 15, 2025. Mr. Ankit Jain has been appointed as Company Secretary and Compliance Officer with effect from December 16, 2025.
Key Highlights
Mr. Vinod Goel appointed as CFO w.e.f. December 16, 2025
Mr. Ankit Jain appointed as Company Secretary w.e.f. December 16, 2025
Mr. Vinod Goel has over 35 years of post-qualification experience
Mr. Ankit Jain has around 15 years of experience
👀 What to Watch
The appointment of a new CFO and Company Secretary is a routine management change. Investors should monitor the company's performance under the new leadership.
